Johnston McGregor offers a wide range of consulting services focused on developing your molecule quickly while providing appropriate information back to investors consulting. We point out ways to navigate the regulatory hurdles and development pitfalls in order to keep the project running smoothly.
Strategic regulatory advice and execution
Strategic clinical advice and execution
Established drug development templates
Drug safety review
DSMB advice and participation
We put together a plan to start, build, grow the company and partner new molecules.
We can minimize drug development costs.
Did you know?
The commonest reasons for inadequate IND filing with the FDA is
inadequate safety information including toxicology and dose estimation?
The commonest reason for failures of drug is inadequate phase II
studies and dose finding?